Every S-3 that Accuray Incorporated (ARAY) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A S-3 covers the shelf registration that lets an established company sell over time, so if you follow ARAY and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ARAY filings page.
Accuray Incorporated (ARAY) has filed Amendment No. 2 to a Form S-3 shelf registration to cover the resale, from time to time, of up to 6,834,308 shares of common stock by certain lending investors. These shares are issuable upon exercise of Super Premium, Premium and Penny Warrants issued in connection with Accuray’s senior secured financing arrangements, including an $18.25 million delayed draw term loan funded on May 19, 2026. Accuray is not offering any shares itself and will not receive proceeds from stockholder resales, but may receive cash if the warrants are exercised for cash, which it currently plans to use for general corporate purposes.
Accuray Incorporated (ARAY) has filed an amended Form S-3 registration statement to permit the resale, from time to time, of up to 6,834,308 shares of common stock by certain existing lenders as selling stockholders. These shares are issuable upon exercise of previously issued Super Premium, Premium and Penny Warrants granted in connection with Accuray’s senior secured Financing Agreement, including an $18.25 million delayed draw term loan facility funded on May 19, 2026.
Accuray is not issuing or selling any new shares in this registration and will not receive proceeds from selling stockholder resales, though it would receive cash if holders exercise the warrants for cash. As of May 31, 2026, 118,963,696 shares of common stock were outstanding. The warrants have exercise prices of $1.50, $1.25 and $0.01 per share and include price-based anti-dilution protection. Accuray’s stock is listed on the Nasdaq Capital Market under the symbol ARAY, having transferred from the Nasdaq Global Select Market effective August 6, 2026; the last reported price on August 20, 2026 was $0.29 per share.
Accuray Incorporated filed a Form S-3 shelf registration covering the resale, from time to time, of up to 6,834,308 shares of common stock by certain lending investors. These shares are issuable upon exercise of three warrant series granted in connection with the company’s senior secured financing.
The registered shares comprise 2,990,010 underlying Super Premium Warrants at $1.50 per share, 2,135,721 underlying Premium Warrants at $1.25 per share, and 1,708,577 underlying Penny Warrants at $0.01 per share. The warrants were issued alongside an $18.25 million delayed draw term loan funded on May 19, 2026.
Accuray is not selling any shares in this offering and will not receive proceeds from Selling Stockholder resales, but would receive cash proceeds if holders exercise the warrants for cash, which it intends to use for general corporate purposes. Common stock outstanding was 118,963,696 shares as of May 31, 2026, and trades on Nasdaq under “ARAY,” which last closed at $0.29 on July 30, 2026.
Accuray Incorporated is registering 7,000,516 shares of common stock for resale by certain lending investors. These shares are issuable upon exercise of three warrant series granted in connection with an amendment to Accuray’s senior secured Financing Agreement dated December 15, 2025.
The registered shares comprise 3,062,726 shares from Super Premium Warrants at a $1.50 exercise price, 2,187,661 shares from Premium Warrants at $1.25 per share, and 1,750,129 shares from Penny Warrants at $0.01 per share. The Super Premium and Premium Warrants are exercisable from June 16, 2026 to December 15, 2032, while the Penny Warrants are exercisable from December 15, 2025 to December 15, 2032.
This is a resale registration; Accuray is not selling shares and will not receive proceeds from resales by the selling stockholders, though it would receive cash if holders choose to exercise the warrants for cash. As of January 30, 2026, Accuray had 118,782,630 common shares outstanding.